News
TriNetX Delivers Public Comments on the Use of Real-World Evidence at the Reagan-Udall Foundation’s 2019 Annual Public Meeting
Cambridge, MA, May 2, 2019 — TriNetX, the global health research network that optimizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today delivered public comments on the use of RWE at the Reagan-Udall Foundation’s...
Hungary’s University of Debrecen Joins TriNetX Network to Increase Collaboration and Growth in Commercial Clinical Studies
Cambridge, MA, April 30, 2019 — The University of Debrecen, one of the oldest continuously operating institutions of higher medical education in Hungary, has joined the TriNetX global health research network to develop collaborative research partnerships with other...
TriNetX’s Real-World Data and Analytics Platform Used to Compare Antihypertensive Treatments and Cardiovascular Events; Findings Published in the Journal of Clinical Hypertension
Cambridge, MA, April 18, 2019 — TriNetX, the global health research network that optimizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that the Journal of Clinical Hypertension has published its...
Journal of Clinical Hypertension – “First‐line treatment of essential hypertension: A real‐world analysis across four antihypertensive treatment classes”
This study was written by Manfred Stapff, MD, PhD, Chief Medical Officer at TriNetX, and Sarah Hilderbrand, MSc and published in the Journal of Clinical Hypertension describing how electronic medical records can be used to analyze and compare actual treatment...
TriNetX, InSite Unite to Establish World’s Largest Clinical Research Network
Acquisition of Belgium-based Custodix Promises to Bring New Pharmaceutical-Sponsored Clinical Trials to Healthcare Organizations Throughout Europe